In light of recent global shocks and rising external volatility, there is a growing need to effectively monitor short-term economic fluctuations, especially in countries with limited access to ...
New FDA guidance on the use of Bayesian statistics signals a broader shift in accommodating more flexible clinical trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results